| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 03/04/1999 | WO1999010365A2 5',5'-linked oligomers having anti-thrombin activity |
| 03/04/1999 | WO1999009998A1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases |
| 03/04/1999 | CA2300146A1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases |
| 03/03/1999 | EP0898575A2 A combinatorial protecting group strategy for multifunctional molecules |
| 03/03/1999 | CN1209747A Modulation of TH1/TH2 cytokine expression by Ribavirin and Ribavirin analogs in activated T-lymphocytes |
| 03/02/1999 | US5877163 Treating aids with 3'-azido-3'-deoxythymidine in combination with interleukin ii or phosphonoformate |
| 03/02/1999 | US5877021 Induction of graft tolerance, treatment of autoimmune diseases, inflammatory disorders and allergies in particular, by inhibition of b7-1, b7-2, b7-3 and cd40. |
| 03/02/1999 | US5876938 Use of boron-containing polynucleotides as diagnostic agents |
| 02/25/1999 | WO1999009411A1 NOVEL COMPOUND 2-AMINO-3-[2-(α-MANNOPYRANOSYL)INDOL-3-YL]PROPIONIC ACID, PROCESS FOR PREPARING THE SAME, AND METHOD FOR INSPECTING FUNCTION OF LIVING BODY WITH THE NOVEL COMPOUND |
| 02/25/1999 | WO1999009203A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes |
| 02/25/1999 | WO1999009044A1 Ribonucleoside-derivative and method for preparing the same |
| 02/25/1999 | WO1999009041A2 Solution phase synthesis of oligonucleotides |
| 02/25/1999 | WO1999009031A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 02/25/1999 | WO1999008688A1 Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments |
| 02/25/1999 | CA2300874A1 Solution phase synthesis of oligonucleotides |
| 02/25/1999 | CA2298630A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes |
| 02/24/1999 | EP0897301A1 Method of treating otitis media with uridine triphosphates and related compounds |
| 02/24/1999 | EP0815114A4 Nucleic acid synthesis using photoremovable protecting groups |
| 02/24/1999 | EP0775149A4 Novel protecting groups and use thereof in an improved process for oligonucleotide synthesis |
| 02/23/1999 | US5874568 Coupling unit of (6-4) photoproduct, process for preparing the same, process for preparing oligonucleotide containing (6-4) photoproduct by using the same and process for preparing DNA containing (6-4) photoproduct by using the same |
| 02/23/1999 | US5874557 Enzyme inhibitors which bind to polymerases at ambient temperatures and prevent amplification of nontarget oligonucleotides during polymerase chain reactions; for accurate diagnosis |
| 02/23/1999 | US5874553 Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 02/23/1999 | US5874413 Cytomegalo virus |
| 02/23/1999 | US5874218 Method for detecting a target compound in a substance using a nucleic acid ligand |
| 02/18/1999 | WO1999008110A1 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 02/18/1999 | WO1999007721A1 Improved process for antiparasitic agent |
| 02/18/1999 | WO1998029108A3 Compositions and methods for restoring a normal pattern of imprinting to cells |
| 02/16/1999 | US5872244 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds |
| 02/16/1999 | US5872243 Caged nucleotides |
| 02/16/1999 | US5872232 2'-O-modified oligonucleotides |
| 02/16/1999 | US5872107 Anticarcinogenic agents capture therapy for tumors |
| 02/16/1999 | US5872096 Modified sialyl Lewisa compounds |
| 02/16/1999 | US5872003 DNA sequencing by mass spectrometry via exonuclease degradation |
| 02/16/1999 | US5871928 Methods for nucleic acid analysis |
| 02/16/1999 | US5871753 A compound comprising two or more multimerized ligands each independently selected from the group consisting of fk506, fk520 and cyclosporin, or macrocyclic derivatives thereof. |
| 02/16/1999 | CA2083386C Phosphorous prodrugs |
| 02/11/1999 | WO1999006424A1 Lyxofuranosyl benzimidazoles as antiviral agents |
| 02/11/1999 | WO1999006422A2 Base analogues |
| 02/11/1999 | WO1999006053A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | CA2297776A1 Base analogues |
| 02/11/1999 | CA2297076A1 Lyxofuranosyl benzimidazoles as antiviral agents |
| 02/11/1999 | CA2296485A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/10/1999 | EP0896063A2 Method for the selection of genetically transformed cells and compounds for use in the method |
| 02/09/1999 | US5869696 Universal solid supports and methods for their use |
| 02/09/1999 | US5869666 4',6'-cyclopropane-fused carboxylic nucleoside analogs in which the oxygen in the ribose ring is substituted for carbon; antimetabolites; locking dna in solution to examine dna-protein, dna-rna and dna-dna interactions |
| 02/09/1999 | US5869641 An isolated modified rna ligand that reacts like an anti-cd4 antibody; treating autoimmune diseases, hiv, antidiabetic and antiarthritic agents |
| 02/09/1999 | US5869464 Having low toxicity, sustaining low concentration in blood for extended period |
| 02/09/1999 | US5869461 Reducing toxicity of L-nucleosides with D-nucleosides |
| 02/09/1999 | US5869337 Regulated transcription of targeted genes and other biological events |
| 02/04/1999 | WO1999005158A1 PROCESS FOR THE PREPARATION OF 2'-FLUORO-5-METHYL-β -L-ARABINOFURANOSYLURIDINE |
| 02/04/1999 | WO1999005157A1 PROCESS FOR PREPARATION OF 2'-FLUORO-5-METHYL-β -L-ARABINOFURANOSYLURIDINE |
| 02/04/1999 | WO1999005156A1 Production of avermectin compounds |
| 02/04/1999 | WO1999005155A2 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 02/04/1999 | WO1999005094A1 Novel compositions for the delivery of negatively charged molecules |
| 02/04/1999 | CA2300695A1 Novel compositions for the delivery of negatively charged molecules |
| 02/03/1999 | EP0894868A2 Process for producing nucleoside derivatives |
| 02/02/1999 | US5866700 Solid-phase synthesis of oligoribonucleotides |
| 02/02/1999 | US5866548 Caged membrane-permeant inositol phosphates |
| 02/02/1999 | US5866378 Process for the synthesis of nucleotide-6-deoxy-D-xylo-4-hexuloses |
| 01/31/1999 | CA2244314A1 Process for producing nucleoside derivatives |
| 01/28/1999 | WO1999003870A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | WO1999003849A1 Fluorescent dibenzazole derivatives and methods related thereto |
| 01/28/1999 | CA2297436A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | CA2295304A1 Fluorescent dibenzazole derivatives and methods related thereto |
| 01/27/1999 | CN1206420A Novel A1 adenosine receptor agonists and antagonists |
| 01/27/1999 | CN1206012A Process for preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine |
| 01/26/1999 | US5864033 Adenosine kinase inhibitors |
| 01/26/1999 | US5864031 Process for preparing 5-dithio-modified oligonucleotides |
| 01/26/1999 | US5864026 Systematic evolution of ligands by exponential enrichment: tissue selex |
| 01/26/1999 | US5863903 Antidiabetic agent |
| 01/26/1999 | CA2131373C 2-aminosugar derivatives of macrolides |
| 01/21/1999 | WO1999002544A1 Compounds having energy transfer function and method for dna base sequencing by using the same |
| 01/21/1999 | WO1999002543A1 3'-deoxyribonucleotide derivatives |
| 01/21/1999 | WO1999002542A1 New formulation |
| 01/21/1999 | WO1999002532A2 Partially hydrogenated polycyclic compounds |
| 01/21/1999 | CA2266031A1 3'-deoxyribonucleotide derivatives |
| 01/21/1999 | CA2265551A1 Compounds having energy transfer function and method for dna base sequencing by using the same |
| 01/20/1999 | EP0891393A1 Asymmetric benzoxanthene dyes |
| 01/20/1999 | EP0767657A4 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 01/20/1999 | EP0641327B1 Novel alpha-mannosidase inhibitors |
| 01/20/1999 | CN1205640A Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase |
| 01/19/1999 | US5861493 Process for the synthesis of 2'-O-substituted pyrimidines |
| 01/19/1999 | US5861492 Solution and solid-phase formation of glycosidic linkages |
| 01/19/1999 | US5861429 13-substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests |
| 01/19/1999 | CA2179987C Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine |
| 01/13/1999 | EP0889728A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 01/13/1999 | CN1041633C Novel 2-thiosubstituted carbapenems |
| 01/12/1999 | US5859234 3'-diisopropylmethylphosphonamidityl-5'-dimethoxytrityl-n4 -isobutyryl-2'-o-methylcytidine monomer do not undergo transamination for efficient oligonucleotide and methylphosphonate oligomer synthesis |
| 01/12/1999 | US5859233 Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates |
| 01/12/1999 | US5859228 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 01/12/1999 | US5859221 Hybrid dna, rna; nuclease resistant |
| 01/12/1999 | US5858660 Parallel selex |
| 01/07/1999 | WO1999000669A1 Nucleobase heterocyclic combinatorialization |
| 01/07/1999 | WO1999000402A1 Purification of oligomers |
| 01/07/1999 | WO1999000399A1 Method of producing tiazofurin and other c-nucleosides |
| 01/07/1999 | WO1998035048A3 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 01/07/1999 | CA2294617A1 Purification of oligomers |
| 01/07/1999 | CA2290364A1 Method of producing tiazofurin and other c-nucleosides |
| 01/06/1999 | CN1203918A Mistletoe extract and its use |
| 01/06/1999 | CN1041523C Crystal form substituted avermectin B1a/B1b benzoin acid salt and its preparing method and use |